Mercodia is a Swedish biotech company committed to delivering products and services with the highest reliability and accuracy. We specialize in developing and manufacturing immunoassays for research and clinical diagnostics, as well as offering bioanalytical services to pharma and biotech companies to support their preclinical and clinical development.

Mercodia’s vision is to improve human health by providing its products and services to scientists around the globe. With more than 30 years of experience, we are a trusted and valued partner to the life science and pharmaceutical communities worldwide.

Mercodia will make its knowledge, experience, and developed tools available to GRIP on MASH for biomarker analyses, encompassing both existing and novel biomarkers. This collaboration aims to enhance our understanding, identification, and diagnosis of MASLD patients in a non-invasive manner.